MAPK1 and breast cancer: The link between substrate rigidity and variation in ERK activity has been established by culturing mammalian cancer cell lines on matrices with different elastic moduli, ranging from healthy tissue stiffness (0.1 kPa) to stiffness of rigid mammary tumours (around 4 kPa).